NEW YORK (AP) — Stocks that moved heavily or traded substantially Monday:
XBiotech, Inc., up $1.21 to $19.57.
The biotechnology company's antibody screening technology will benefit from the FDA's emergency authorization of plasma for COVID-19 patients.
Catalent Inc., up $1.97 to $88.46.
The maker of drug delivery systems expanded its manufacturing support deal with AstraZeneca for a potential COVID-19 vaccine.
Churchill Downs Inc., down $1.69 to $172.54.
The racetrack operator and gambling company will run the 146th Kentucky Derby without fans in attendance.
AstraZeneca Plc., up $1.05 to $56.76.
The U.S. is considering fast-tracking the drug developer's potential COVID-19 vaccine, according to media reports.
JPMorgan Chase & Co., up $2.74 to $100.06.
Banks made broad gains as global markets rallied around hopes for a coronavirus vaccine and continued economic recovery.
American Airlines Group Inc., up $1.28 to $13.44.
Airlines made gains as hopes for a COVID-19 vaccine raised the possibility that demand for travel will recover.
Gilead Sciences Inc., down 42 cents to $66.08.
The biotechnology company's drug remdesivir showed disappointing results as a COVID-19 treatment in a published study.
Barrick Gold Corp., down 34 cents to $28.97.
The price of gold slipped as investors turned away from safe-play holdings.
Before you consider Barrick Gold, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Barrick Gold wasn't on the list.
While Barrick Gold currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
